Sapient Laboratories Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 30-12-2024
- Paid Up Capital ₹ 5.00 M
as on 30-12-2024
- Company Age 21 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 Cr
as on 30-12-2024
- Satisfied Charges ₹ 4.13 Cr
as on 30-12-2024
- Revenue 34.35%
(FY 2022)
- Profit 2.40%
(FY 2022)
- Ebitda 15.22%
(FY 2022)
- Net Worth 6.55%
(FY 2022)
- Total Assets 11.17%
(FY 2022)
About Sapient Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹4.13 Cr, as per Ministry of Corporate Affairs (MCA) records.
Prem Verma, Surinder Bhat, Anita Shahi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231DL2003PTC118652
- Company No.
118652
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sapient Laboratories Private Limited offer?
Sapient Laboratories Private Limited offers a wide range of products and services, including Nasal Drops, Eye Care Medicines, Eye Drops, Xylometazoline Nasal Drops, Carboxymethylcellulose Sodium Eye Drops, Ear Drops, Pharmaceutical Syrup, Dry Syrups, Eye Cosmetic, Eye Gel.
Who are the key members and board of directors at Sapient Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prem Verma  | Director | 27-Jan-2003 | Current |
| Surinder Bhat | Director | 27-Jan-2003 | Current |
| Anita Shahi | Director | 22-Dec-2010 | Current |
| Ravish Singh | Director | 27-Jan-2003 | Current |
Financial Performance of Sapient Laboratories.
Sapient Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 34.35% increase. The company also saw a slight improvement in profitability, with a 2.4% increase in profit. The company's net worth moved up by a moderate rise of 6.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sapient Laboratories?
Unlock access to Sapient Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Anemone Wellness Private LimitedActive 1 year 5 monthsPrem Verma and Ravish Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 26 Nov 2021 | ₹3.00 Cr | Open |
Bank Of India Creation Date: 14 Aug 2020 | ₹2.26 M | Satisfied |
Bank Of India Creation Date: 24 May 2019 | ₹1.49 M | Satisfied |
How Many Employees Work at Sapient Laboratories?
Sapient Laboratories has a workforce of 122 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sapient Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sapient Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
